Popular search terms:
Search Results Label
84 results found-
Influenza is a common, highly contagious infection that can lead to life-threatening complications. Learn more about influenza and our cutting-edge vaccines.
https://www.seqirus.com/expertise/influenza -
Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.
https://www.seqirus.com/expertise -
Seqirus Begins Shipping 2020/21 Influenza Vaccines to U.S. Market
https://www.seqirus.com/news/seqirus-begins-shipping-influenza-vaccines-to-us-market -
Seqirus Presents Real-World Data for Cell-Based Quadrivalent Seasonal Influenza Vaccine (QIVc) at ESWI 2020
https://www.seqirus.com/news/seqirus-presents-real-world-data-for-cell-based-quadrivalent -
Seqirus Presents New Late-Breaking Data at ESWI 2020
https://www.seqirus.com/news/seqirus-presents-new-late-breaking-data-at-eswi-2020 -
Seqirus has been on the front line of pandemic preparedness for more than a century. Learn more about our rapid vaccine production capabilities.
https://www.seqirus.com/expertise/influenza/pandemic-response-solutions -
This EU Flu Day, Seqirus confirms record number of influenza vaccines delivered across Europe to meet increased demand
https://www.seqirus.com/news/eu-flu-day-seqirus-confirms-influenza-vaccines-delivered-across-eu -
Seqirus employs both egg and cell-based manufacturing systems to ensure the availability of our influenza vaccines. Learn more about our optimised technology.
https://www.seqirus.com/manufacturing/technologies -
First adjuvanted quadrivalent influenza vaccine receives EU approval
https://www.seqirus.com/news/first-adjuvanted-quadrivalent-influenza-vaccine--receives-eu-approval -
Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.
https://www.seqirus.com/our-company